Startseite>>Signaling Pathways>> Proteases>> Acyltransferase>>GOAT-IN-1

GOAT-IN-1

Katalog-Nr.GC31080

GOAT-IN-1 ist ein Inhibitor der Ghrelin-O-Acyltransferase (GOAT), der fÜr die Prophylaxe oder Behandlung von Fettleibigkeit, Diabetes, HyperlipidÄmie, metabolischer, nicht-alkoholischer Fettleber, Steatohepatitis, Sarkopenie, Appetitkontrolle, Alkohol/ DrogenabhÄngigkeit, Alzheimer-Krankheit, Parkinson-Krankheit, zerebrovaskulÄre Demenz, zerebrale Apoplexie, Hirninfarkt, Herzerkrankungen, irgendeine Art von Tumoren.

Products are for research use only. Not for human use. We do not sell to patients.

GOAT-IN-1 Chemische Struktur

Cas No.: 1452473-54-9

Größe Preis Lagerbestand Menge
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT), which could be useful for the prophylaxis or treatment of obesity, diabetes, hyperlipidemia, metabolic, non-alcoholic fatty liver, steatohepatitis, sarcopenia, appetite control, alcohol/narcotic dependence, Alzheimer's disease, Parkinson's disease, cerebrovascular dementia, cerebral apoplexy, cerebral infarction, cardic disease, some kind of tumors.

The inhibitory activity of GOAT-IN-1 (Example 16) for human GOAT is 101% with the concentration of 10 μM[1].

[1]. WO 2013125732.

Bewertungen

Review for GOAT-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GOAT-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.